1. | tmk499596 | |
2. | wjmcgrath | |
3. | 7942usculbe | |
4. | techwood |
1. | tmk499596 | |
2. | wjmcgrath | |
3. | 7942usculbe | |
4. | techwood |
1. | techwood 01/22/2018 Holding for longterm tho |
2. | tmk499596 01/22/2018 Well... we are moving here |
3. | wjmcgrath 04/26/2018 uniQure Delivers Oral Presentation on Broad Set of Preclinical Data on AMT-130 in Huntington's Disease at the 2018 American Academy of Neurology Annual Meeting |
4. | wjmcgrath 12/03/2018 uniQure Announces Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 and Confirms Dose for AMT-061 Pivotal Study in Hemophilia B |
5. | tmk499596 01/08/2018 News...hmmm, stock droppin... |
6. | 7942usculbe 03/14/2018 uniQure Announces 2017 Financial Results and Recent Company Progress |
7. | tmk499596 01/22/2018 Company has received an Orphan Medicinal Product Designation (OMPD) from the European Medicines Agency for AMT-130 in Huntington’s disease. |
8. | wjmcgrath 05/21/2018 Presents data showing successful liver transduction |